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 1 
A comparison of ultrasound with magnetic resonance 
imaging in the assessment of fetal biometry and weight 
in the second trimester of pregnancy:  An observer 
agreement and variability study.  
 Keywords  
‘Biometry’, ‘Fetal weight’, ‘Fetus’, ‘Observer variation’, ‘Magnetic Resonance 
Imaging’, ‘Ultrasonography’, ‘Pregnancy trimester, second’. 
Abstract 
Objective 
To compare the intra and interobserver variability of ultrasound (US) and magnetic 
resonance imaging (MRI) in the assessment of common fetal biometry and estimated 
fetal weight (EFW) in the second trimester. 
Methods 
Retrospective measurements on pre-selected image planes were performed 
independently by two pairs of observers for contemporaneous US and MRI studies of 
the same fetus.  Four common fetal measurements (BPD, HC, AC, FL) and an 
estimated fetal weight (EFW) were analysed for 44 ‘low risk’ cases. Comparisons 
included, intra class correlation coefficients (ICC), systematic error in the mean 
differences, and the random error. 
Results 
The US inter- and intraobserver agreement were good, except for intraobserver AC 
(ICC = 0.880), with a significant increase in error with larger AC sizes.  MRI 
produced excellent intraobserver agreement with higher ICCs than US. Good MRI 
interobserver agreement was comparable with US except for the BPD (ICC = 0.942, 
moderate). Systematic errors between modalities were seen for the BPD, FL and EFW 
(percentage error = +2.5%, -5.4% and -5.5% respectively, p<0.05). MRI had less 
random error than US for intraobserver HC, FL and EFW measures   (p<0.05), and 
more interobserver error for the FL and EFW (p<0.05). 
Conclusions 
US remains the modality of choice when estimating fetal weight, however with 
increasing application of fetal MRI a method of assessing fetal weight is desirable. 
Both methods are subject to random error and operator dependence.  Assessment of 
calliper placement variations, may be an objective method detecting larger than 




Accurate evaluation of fetal size and growth is essential for the delivery of good 
quality antenatal care, and ultrasound (US) measurements play a central role. When a 
US scan indicates that a fetus is appropriately grown this suggests good intrauterine 
health, thus is reassuring to the clinician and the parents. Additionally, an accurate 
antenatal detection of a growth abnormality may raise suspicions of a variety of fetal 
and maternal conditions which include; pre-eclampsia; fetal growth restriction, 
(FGR); gestational diabetes; macrosomia; infection; and syndromic or genetic 
conditions which are associated with changes in growth patterns (1,2). The 
information about fetal size is a marker of overall fetal health, and may act as a 
threshold for clinicians who, based on the findings, could offer further investigations 
such as Doppler US, blood tests, amniocentesis, or be used to plan the timing of 
delivery of a compromised fetus (3). However, ultrasound is known for its large 
random errors in fetal measurement and low sensitivity for detecting growth 
disturbances (2,4).  Furthermore, there is growing evidence that magnetic resonance 
imaging (MRI) can result in estimated fetal weight (EFW) with far less error than 
ultrasound, particularly when using volumetric methods (5-7).  Few studies have 
assessed the validity of MRI by radiologists for the measurement of fetal biometry 
compared to US by sonographers (8-10).  Furthermore, a literature search revealed no 
studies which had performed a comprehensive intra- and inter-rater agreement, 
variability and method comparison of US and MRI for fetal biometry and estimated 
fetal weight (EFW). Additionally, reporting standards of method comparison studies 
vary widely which limits their interpretation (11-14).  
Fetal MRI is a highly specialised modality for fetal diagnosis and is well established 
for fetal central nervous system (CNS) anomalies.  A systematic review of 13 peer 
reviewed articles, found that MRI provided supplementary information to US and 
resulted in a change in clinical management in 30% of cases, with referral indications 
being numerous but including; posterior fossa anomalies, corpus callosal anomalies, 
microcephaly or apparently isolated ventriculomegaly (15,16). However, MRI is also 
increasing in its remit for fetal evaluation of anomalies outside the CNS e.g. 
diaphragmatic hernia, pulmonary anomalies and twin to twin transfusion syndrome, 
particularly when US is limited by reduced amniotic fluid, maternal obesity or in the 
presence of equivocal US findings (16-19).  A survey conducted by the International 
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Society of Ultrasound in Obstetrics and Gynaecology (ISUOG), found that at least 1-2 
centres in 27 countries were performing fetal MRI with the quality of imaging, 
sequences used and operator experience varying widely.  In the UK, fetal MRI is 
offerd by some tertiary units who have a fetal medicine department (currently 
approximately 6 UK wide), and may involve outsourcing of image reporting to 
experienced specialists.  ISUOG also suggests that a standardised and complete 
assessment of fetal anatomy is feasible with MRI, however its current remit is to 
complement an expert US examination (16).   
As the use of clinical fetal MRI increases, modality specific biometric evaluation is 
becoming more important. Previous studies have almost exclusively focussed on fetal 
MRI late in gestation, however women may be referred for a fetal MRI scan soon 
after the 20 week anomaly US scan when anomalies are initially suspected (3,20).  
The aim of this study is to compare the intra and interobserver variability of US and 
MRI in the assessment of common fetal biometry and EFW in the second trimester. . 
Design and Methods  
The intelligent fetal imaging and diagnosis project (iFIND) is a large scale, single 
centre observational imaging and engineering project, whose aim is to use novel 
technologies to improve diagnosis and detection rates in the second trimester of 
pregnancy.  The project has been granted NHS Research and Development 
approval and ethics approval, NRES reference number = 14/LO/1806, (trial 
registry numbers: UKCRN ID = 18283, ISRCTN = 16542843).  All participants gave 
written and informed consent.   
The study is divided into iFIND-1 where 10, 000 clinical mid-trimester anomaly 
ultrasound scans are recorded for the purposes of machine learning and big data 
analysis, and iFIND-2 which involves further imaging on a smaller population in 
addition to the anomaly scan.   iFIND-2 includes a 2D and 3D US, as well as a MRI 
on each fetus, and these paired datasets are obtained within 0 to 3 days. The images 
were retrospectively and consecutively collected from the iFIND-2 datasets of fetuses 
with a normal anomaly scan result. The image planes pre-selected included the 
biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC) 
and femur length (FL) (see figures 1-8 for example image planes and measurement 
criteria).  To calculate the EFW for each fetus (MRI and US) the Hadlock formula 
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including the HC, AC and FL measurements were used as recommended by the 
British Medical Ultrasound Society and ISUOG (20-22).  Whilst the BPD 
measurement is useful to assess head shape its variability in measurement suggests it 
should not be used in routine EFW calculation (23). 
The ultrasound system was a Philips Epiq (Philips Healthcare, Best, Netherlands) and 
the participants were examined by one of two operators (JM or CK), a Consortium for 
the Accreditation of Sonographic Education, CASE, accredited sonographer with 10 
years scanning experience and a UK trained fetal medicine specialist with 6 years’ 
experience respectively.  A 6-1 mHz matrix probe was used to scan all patients.  The 
MRI scanner used for all participants was a Philips Ingenia 1.5 Tesla system (Philips 
Healthcare, Best, Netherlands).  Motion corrected MRI slice to volume 
reconstructions of the fetal head were used to find a transventricular plane comparable 
to US imaging (24)..   An US and a MRI database of anonimysed paired scans was 
compiled using the Osirix image review software for off-line/remote review (version 
7.5, Geneva, Switzerland).  The databases were duplicated then the images reordered 
randomly, ready for a repeat review by the observers after 2.5 weeks, with the aim of 
reducing any recall bias.  All reviewers were provided with face to face training and 
guidance notes about; which views to be recorded; the use of the Osirix review 
platform; and optimal viewing conditions for the off-line review.  
Using both of the US databases, one sonographer (TF, a UK trained sonographer with 
3 years scanning experience) performed repeated measures (blinded to MRI and any 
previous measurements), this was used for US intraobserver calculations. The fetal 
medicine specialist (CK) independently performed one US reading from the first 
database, for interobserver calculations. Using both the MRI databases one radiologist 
(KP, 5 years fetal MRI clinical experience) performed repeated measures (blinded to 
the US and any previous measures) and a fetal imaging research radiographer (CM, 
10 years fetal MRI research experience) independently performed one MRI reading 
from the first database.  The observers also recorded a 3 scale image quality score for 
each image (1=poor, 2=satisfactory and 3=good).  Data was collected on an Excel 
spreadsheet and all supplementary materials and raw data was to be deposited at the 
University via a Research Data Management System on completion of analysis. 
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Figures 1 - 8: Image planes and measurement criteria 
Image plane selection and calliper placement criteria was obtained from the NHS fetal 
anomaly screen programme guideline (20). 
Head Circumference (HC), transventricular view  
Figure 1: US HC plane    Figure 2: MRI SVR HC plane 
[place figure 1 here]     [place figure 2 here] 
 
 
In the transventricular view, the image plane was at the level of the cavum septum 
pellucidum anteriorly (*) and the lateral ventricular horn posterior containing the 
choroid plexus (^).  The falx cerebri was mid-line (“) and the head an oval shape.  The 
ellipse tool was used to measure around the outer table of the skull, being careful not 
to include any subcutaneous fat.  The MRI transventricular view was carefully 
selected from slice to volume reconstructions (SVR) (24) obtained from T2 dynamic 
sequences (TR/TE = Longest/80, slice Th/gap = Volume/-1.25) which were 
manipulated in Osirix using the multiplanar reconstruction (MPR) mode.  
 
Biparietal Diameter (BPD), transventricular view 
Figure 3: US BPD plane    Figure 4: MRI SVR BPD plane 
[place figure 3 here]     [place figure 4 here] 
 
 
In the same image plane as the for the HC measurement, the BPD was measured from 
the outer table of the skull to the outer table of the skull at the widest part for both 




Abdominal Circumference (AC) 
Figure 5: US AC plane    Figure 6: MRI AC plane 
 
[place figure 5 here]     [place figure 6 here] 
 
 
The AC measurement was obtained with an ellipse tracing. The image plane was at a 
level including the part of the fetal liver (*), the fetal stomach (^), the portal sinus of 
the umbilical vein (“), 3 bony points of a vertebra in cross section (+), a circular 
abdominal appearance, circular aorta (>) and with a short length of a rib, i.e. 
‘unbroken’ (‘).  The MRI sequence most commonly selected with the correct plane, 
was a T2 fast spin echo sequence of the transverse uterus (TR/TE = 920/90, slice 
Th/gap = 4/0), followed by the single shot fast spin echo. 
 
Femur Length (FL) 
Figure 7: US FL plane    Figure 8: MRI FL plane 
[place figure 7 here]     [place figure 8 here] 
 
 
The FL was measured by placing the callipers at the end of the diaphysis in a view 
where the femur does not appear foreshortened (solid line). Care was taken to avoid 
measuring the cartilaginous epiphysis at either end of the femur and also to avoid the 
greater trochanter which otherwise would falsely elongate the measurement. The MRI 
sequence most commonly found to have a clear view of the femur in the correct plane 
was a DWI sequence in the B0 field i.e. before the diffusion weighting was applied, 
(TR/TE = 4000/89, slice Th/gap = 5/0).  Some MRI femur views were well visualised 
using a gradient echo echoplanar imaging sequence. 
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Statistical analysis 
The data was analysed using the statistical packages, SPSS (version 23, SPSS Inc, 
Chicago, Ill, USA) and Excel, (version 14.4.7, Microsoft Corp. Redmond, 
Washington, USA).  The EFW was calculated using the Hadlock formula (25).  A 
power calculation determined that a sample size of 31 was required to give a power of 
80% for an error of 5% to detect an effect size of 1 mm difference (assuming a 
standard deviation of 8mm).  Normality testing was performed to ensure assumptions 
were met for statistical analysis and to identify any obvious outliers. 
To assess systematic error between the modalities, the mean difference in 
measurement from the two observers per modality was compared for each parameter 
(BPD, HC, AC, FL, and EFW).  A two tailed paired t-test was performed to compare 
the means. 
To test the intra and interobserver agreement, the average measures intra class 
correlation coefficient, ICC was used.  Suggested cut off limits proposed in the 
literature for fetal studies guided interpretation (26). 
Bland Altman plots were used to graphically assess the mean difference and the limits 
of agreement, LoA. A linear regression coefficient was used to determine if there was 
a statistically significant proportional bias in the error as the size increased.   
Random error was compared between modalities using the LoA (+/-1.96SD of the 
mean) as a marker of intra and interobserver variability and a two tailed paired t-test 
was performed. 
Finally, to allow the clinical significance to be interpreted more readily, the 
proportion of cases falling outside of a calliper placement error threshold was 
calculated.  Arbitrary thresholds were determined by previous examples of expected 
error in the literature (4).  In addition, a standard deviation (SD) threshold for each 
parameter was determined using 1SD of the US intraobserver measurements 
observed. A number and percentage of cases falling outside of the threshold ranges 
were tabulated and compared between MRI and US. 
Results 
53 consecutive iFIND-2 participants were recruited between November 2015 and 
April 2016 and had their fetal imaging studies reviewed for inclusion.  44 participants 
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(83%) had fully paired datasets, and of these 25 (47%) had complete datasets and 19 
(36%) were partially complete. Nine cases were excluded from the study because: 
four did not attend both scans; two had no transventricular US scan plane available; 
two had failed or poor quality MRI head SVRs; and two had missing US images. 
The gestational age, (GA), was a mean of 23.5 weeks (range 20.3 – 25.7).  The BMI 
was a mean of 26.3kg/cm (range 22.2 – 38.4kg/cm), with 3 cases above 30kg/cm 
(clinically obese).  68% of US and MRI scans were on the same day, 4% had a 2 day 
interval and 24% had a 3 day interval. 84% of the US scans had a satisfactory mean 
image score and 16% had a good score.  For MRI, 8% had a poor mean score, 80% 
had a satisfactory score and 12% had a good score.   
Table 1: Difference in the mean US and MRI biometric measurements and EFW 
 
 
Table 1 demonstrates that MRI systematically measured the BPD larger than US 
(mean percentage error = 2.5%, or 1.5mm, p = 0.001), and the FL smaller than US 
(mean percentage error = -5.4%, or -2.2mm, p = 0.001).  MRI systematically 
measured the EFW smaller than US, (mean percentage error = -5.5%, or -34.8g, 
p<0.05). The mean measurements of the HC and AC compared well between 
modalities.  
After normality testing, two outliers were removed from the dataset for the 
subsequent analysis. One was an obvious data input error for the MRI BPD (case 6) 
and one was a significant measurement error due poor image quality of a T2 sequence 
for bone (case 18).  Only one other outlier was identified for US AC, however it was 
Measurement n US, Mean, 
mm  
MRIbiom, 
















-1.5   
(-2.2 - -0.8) 
-2.5 <0.001 





(-1.4 - 1.5) 
0.3 0.9 





(-2.3 – 4.5) 
0.6 0.5 





(1.0 – 3.7) 
5.4 0.001 








unclear if this was a data input error or a true observer measurement so was kept for 
the remaining analysis (case 41, see figure 13). 




US ICC (95% CI) MRI ICC (95%CI) 
Intraobserver 
 BPD (28)  0.982, good, (0.959 - 0.992)  
 
0.995, excellent, (0.988 - 0.997)  
 
HC (28) 0.952, good, (0.580 - 0.986) 0.997, excellent, (0.994 - 0.999) 
AC (40) 0.880, poor, (0.772 -0.937) 
Significant proportional 
bias, p <0.05  
0.994, excellent, (0.988 - 0.997) 
 
FL (31) 0.978, good, (0.944- 0.990) 
 
0.989, good, (0.975 -0.995) 
 
EFW (23) 0.972, good, (0.547 - 0.993) 0.983, good, (0.961 – 0.993) 
Interobserver 
 BPD (28) 0.974, good, (0.808 - 0.992) 
 
0.942, moderate, (0.860 – 0.974)  
 
HC (28) 0.971, good, (0.938 - 0.987) 
 
0.983, good, (0.963 -0.992) 
 
AC (40) 0.967, good, (0.896 -0.982) 
 
0.973, good, (0.949 -0.986) 
 
FL (31) 0.990, good, (0.979 -0.995) 
 
0.978, good, (0.955 -0.990)  
 
EFW (23) 0.988, good, (0.965 - 0.995)  
 
0.964, good, (0.905 -0.986) 
 
   
Table 2 shows that MRI had excellent intraobserver agreement for BPD, HC, AC, 
EFW and good FL agreement, with all ICC results scoring higher than US.  Only the 
intraobserver FL and EFW had overlapping confidence intervals between modalities 
suggesting significant differences in agreement for the remaining biometry. US had 
good intraobserver agreement for all parameters except AC which scored poorly (ICC 
= 0.880).   In addition, there was significantly less agreement for the US AC 
intraobserver measurement as the AC absolute size increased (p < 0.05).   
For interobserver agreement US and MRI both had good agreement for all parameters 
except for the MRI BPD (moderate ICC = 0.942), however all parameters had 
overlapping 95% confidence intervals, suggesting no significant difference.  
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Figure 9-18:  Bland Altman Plots of US compared to MRI, showing mean absolute error, 
mm, and limits of agreement, LoA, (+/- 1.96 SD) above and below the mean.                                                  
US = blue circles, o and solid lines            , MRI = green crosses, x and dashed line  --------  
Figure 9 Intraobserver BPD    Figure 10 Interobserver BPD 
 
 
[place figure 9 here]     [place figure 10 here] 
 
 
Figure 11 Intraobserver HC     Figure 12 Interobserver HC 
 
 
[place figure 11 here]     [place figure 12 here] 
 
 
Figure 13 Intraobserver AC    Figure 14 Interobserver AC 
 
 




Figure 15 Intraobserver FL    Figure 15 Interobserver FL  
 
 




Figure 17 Intraobserver EFW    Figure 18 Interobserver EFW 
 




The Bland Altman plots in Figures 9-18 shows the absolute difference in millimeters 
between two measurements for each individual case. The MRI and US differences are 
overlaid on the same plot with a central mean difference line and a limits of 
agreement line above and below to represent 95% of the variance.  Only intraobserver 
AC showed an increase in variation with size, with a marginal increased seen with 
intraobserver FL that was not significant.   The LoA varied between parameters, with 
a tendency for MRI LoA to be narrower than US for intraobserver measures and 
wider for interobserver measures.   
In table 3, the LoA (random error) are explored further, and demonstrates that 
statistically significant differences were observed for the intraobserver LoA for HC, 
FL and EFW, with MRI having less variation than US (P<0.05).  There were 
significant differences in the interobserver LoA for AC and FL, with MRI having 
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more variation than US (p <0.05).  Parameters where the mean variation was above an 
arbitrary 5% percentage error threshold, included the intraobserver US measures of 
AC, FL and EFW (8.7%, 5.0% and 6.6% respectively) and MRI EFW (6.2%).  For 
interobserver measures, the parameters for MRI with a mean percentage error above 
5% include BPD, AC, FL and EFW (5.0%, 5.5%, 6.9% and 10.1% respectively) .  For 
US, only interobserver EFW had and a mean percentage error of more than 5% 
(6.2%). 
Table 3: Differences in random error between US and MRI fetal measurements and 





 US MRI  p-value US MRI  p-value 
Absolute error, mm, (+/- 1.96 SD)  
BPD (28) 1.4 1.1  0.3 1.3 3.1 0.8 
HC (28) 7.1 2.5 <0.05 7.9 6.2 0.6 
AC (40) 18.0 5.1 0.09 8.7  10.3 <0.05 
FL (31) 2.1 1.6 <0.05 1.6 2.6 0.99 
EFW, g (23) 45.6 73.2 0.1 43.0 54.2 0.6 
Percentage error, %, (+/- 1.96 SD)  
BPD (28) 2.4% 1.8% 0.3 2.2% 5.0% 0.9 
HC (28) 3.2% 1.2% <0.05 3.6% 2.8% 0.6 
AC (40) 8.7% 2.7% 0.1 4.6% 5.5% <0.05 
FL (31) 5.0% 4.2% <0.05 3.8% 6.9% 0.97 
EFW, g (23) 6.5% 13.6% 0.2 6.3% 8.9% 0.8 
 
Table 4:  Differences in proportion of US and MRI cases falling outside of arbitrary error 
threshold  
Arbitary cut off Intraobserver > threshold Interobserver > threshold 















BPD  28 1.4/2.2  1 (4) 1 (4) 0 (0) 6 (21) 
HC 28 5.2/8.0  11 (39) 0 (0) 2 (7) 1 (4) 
AC  40 7.9/11.0  16 (15) 0 (0) 1 (3) 3 (8) 
FL  31 2.1/2.5  3 (10) 0 (0) 0 (0) 2 (6) 
EFW  23 66.1g (10%) 2 (13) 3 (0) 0 (0) 0 (0) 
Total number of cases measures of 
range (n=150) 
33 (22) 4 (3) 3 (2) 12 (8) 
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Table 5:  Differences in proportion of US and MRI cases falling outside of 1 SD error 
threshold  
 
1 SD cut off Intraobserver > threshold Interobserver > threshold 













BPD  28 0.6  13 (46) 8 (29) 16 (57) 17 (61) 
HC 28 2.8 15 (54) 1 (4) 10 (36) 6 (21) 
AC  40 3.3 19 (48) 8 (20) 21 (53) 17 (43) 
FL  31 1.1 7 (23) 6 (19) 5 (16) 9 (29) 
EFW  23 33.1g (5%) 8 (35) 10 (43) 4 (17) 6 (26) 
Total number of measures out of 
range (n = 150) 
62 (41) 33 (22) 56 (37) 55 (37) 
 
Table 4 demonstrates that more US cases that fell outside of the anticipated error 
range when compared to MRI (32 US cases versus 1 case for MRI), with MRI 
performing equal to, or better than, US for all parameters.  For interobserver error 15 
MRI cases and 3 US cases fell outside the expected threshold for error, with US 
performing better than MRI for BPD, AC, FL and EFW.    
Table 5, with narrower thresholds (based on intraobserver US SDs), demonstrated 
MRI measurements that consistently had less cases falling out of range compared to 
US for intraobserver measures (62 US cases versus 33 MRI cases).  For interobserver 
cases there were 56 US cases and 55 MRI cases in total with larger error.  For 
intraobserver EFW with SD thresholds, the MRI measurements appeared to perform 
better than US with less cases with large variations i.e. >5% (8 cases or 35%, versus, 
2 cases or 9%). 
Discussion  
This study sought to comprehensively compare the intra- and interobserver variability 
between MRI and US for fetal measurements and EFW.  The calliper placement error 
for both US and MRI were found to be small (less than 5%), however the random 
errors observed were expected to be smaller than in clinical practice because of the 
highly controlled conditions (one image plane selected per participant and low risk 
fetuses), thus should be interpreted with caution. US was more susceptible to 
intraobserver variability, whereas MRI was more susceptible to interobserver 
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variability, both having cases falling outside of previously published error thresholds 
for fetal measurements (4).   The causes of random errors in the US measurements 
that are used to calculate EFW, are multifactorial in origin and include; fetal position; 
maternal adiposity; sonographer experience; equipment specification; and reduced 
amniotic fluid which could limit the view (4,27,28).  Observer variation, is known to 
have a major impact on the precision of US fetal measurements, with electronic 
calliper placement on an image, accounting for 58-80% of the error, having more 
impact than maternal adiposity or fetal position (4,5). This highlights the need for 
thorough operator training and audit but also the need for technological development 
of more quantifiable and less subjective assessments (29).   
Sarris et al in 2012, investigated fetal biometry variation in 175 cases with three 
experienced sonographer observers, and found intraobserver variation to be 
consistently smaller than intraobserver variation. The poorer US intraobserver 
measurements (compared to inter- variation)  observed in this study was surprising, 
and highlights the need for objective measurement audits in departments on an 
individual basis because this has a direct impact clinically when serial scans are 
performed often by different operators.  For MRI, the wider interobserver error was 
expected as these fetal measurements are rarely measured routinely and the operator 
experience thus limited.  Fetal MRI staff not experienced in performing these 
measurements will need more training in the future and there is a case for objective 
validation and also for US and MRI specialists to work across disciplines, developing 
practice that compliment one another. MRI currently has no universally agreed 
modality specific growth charts validated for clinical use, largely because; MRI is a 
relatively new tool with less reference data available; most fetal MRI examinations 
are for the brain or spine where the technique is better established, and; there is an 
assumption that the routinely utilised US reference data and growth charts are suitable 
to use across the two modalities (9,30). 
The larger US intraobserver variation and increased variation with increased size for 
the AC measurements, from which the EFW formulae are based, suggests a 
measurement that should be closely monitored.  Previous studies have supported the 
finding that AC measurements have less variation than EFW and therefore be a better 
predictor of size at term (31), however here we demonstrate that the role of the 
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operator is still very important.  A tool to assess calliper placementt, monitoring 
groups of ultrasound operators, could use z-scores or relative percentage error to 
assess departmental and individual variance across time or as a training tool (4).   
Whether using US or MRI, operator dependence in obtaining fetal biometry reaffirms 
the importance of quality training and audit to reduce random errors and 
recommendations have been published in the literature for sonographers (28,32-34).  
The EFW variability suggests that the random errors in fetal measurements will often 
compound the systematic errors of the mathematical equation, whether using US or 
MRI (35).  Indeed, Khel et al, 2012 suggests that the current accuracy of EFW has 
reached its limits, and that novel approaches to US technology must be considered to 
reduce clinical errors. 3D US volumes of a part of a fetusus’ limb, which incorporates 
soft tissue, has been used in EFW calculations, with some success, to improve 
accuracy, however as yet, there is a paucity of diagnostic accuracy tests to validate its 
use clinically (27,36-38), and reductions in post processing time is needed to make 
this a useful tool in the future (1,2).  Significant variation in EFW calculations has 
clinical implications because currently US is not recommended to screen the low risk 
population for growth disturbances due to poor sensitivity and specificity (39).  
Additionally, errors in the formula occurs at the extremes of the weight range, due to 
changes in the soft tissue fat/muscle ratio of a compromised fetus, and may result in 
an overestimation of weight in small babies and an underestimation of weight in large 
babies when accurate depiction is most clinically important (40).   
There is growing evidence that volumetric magnetic resonance imaging (MRI) can 
result in EFWs compared to birthweight with less random error than US, reported as 
low as 1-3% versus up to 7% for US (5,9,41,42).  MRI is well established as a 
multiplanar reconstruction (MPR) imaging technique which means that two-
dimensional images from a 3D volume of data can be reconstructed and viewed in 
any orientation, thus theoretically reducing measurement errors caused by an oblique 
or off centre plane.  Moreover, MRI can negate some of US’s technical drawbacks 
because maternal size, amniotic fluid and fetal position are less of a problem due to 
MRIs increased field of view.  Still, fetal movements in MRI can cause image 
degradation, particularly at earlier gestations when the fetus is more active, and 
results in a poorer signal-to-noise ratio. However, MRI has superior soft tissue 
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contrast and improved boundary definition when placing electronic callipers for 
measurement or when outlining segments of the fetal body to calculate a volume.  
Although MRI is underused as an antenatal tool compared to US, it is increasing its 
remit within fetal imaging for complex or equivocal cases due to improvements in 
post processing and faster scan sequences that reduce the issues of fetal movement 
MRI, and it is based on non-ionising radiation and is considered safe to use in 
pregnancy (43,44).  Nonetheless, the use of MRI is limited by its expense, lack of 
expertise and scanner availability, as well as the limited evidence base of MRI’s 
advantages over obstetric US for non-central nervous system anomalies.Differences 
in the imaging physics of each method are likely to account for the systematic error in 
the mean measurement between modalities (9,11).  For example, the use of T2 
weighted MRI images could mean the anatomical landmarks are slightly different to 
US, e.g. more subcutaneous scalp tissue may have been included due to the poorer 
bone definition.  Distortion effects of the echoplanar imaging sequences used to select 
a FL plane on MRI may have resulted in the smaller FL measured. Technical 
refinement of MRI sequences may be necessary for a comparable and representative 
assessment of fetal anatomy  
A major strength of the study was the adherence to current literature on reliability and 
agreement studies, the use of recommended statistics and guidance on interpretation, 
thus avoiding some of the heterogenous methods used in previous publications (11-
13,26). As a retrospective study, limitations in the sample size occured due to the 
availability applicable of datasets, the short timeframe for the study, and lack of 
control over image quality was an issue.  Also, a prospective study would mean real 
time US (as in clinical practice) could reveal the true variability. Furthermore, US was 
used as the reference standard to compare MRI – however it is well documented that 
the technique is prone to errors   Due to the small numbers no statistical assessment of 
confounders (e.g. BMI, or fetal position) could be attempted.  Furthermore, it may 
have been helpful to report the findings in terms of gestational age to aid easy 
interpretation by the clinician. 
Future research should investigate the role of whole fetal body volume segmentation 
by MRI (or US) in the assessment of fetal weight as the technology continues to 
develop at a rapid pace (5,27,36).  Methods to assess measurement variability as part 
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of individual and departmental audit should also be investigated as part of audit or 
training programmes, with the aim of providing much needed objective quality 
assurance. 
Conclusion 
US remains the modality of choice when assessing biometry and estimating fetal 
weight. However with increasing applications of fetal MRI, a method of assessing 
fetal growth and weight is desirable. Both methods are subject to random error and 
operator dependence, with US being more operator dependant and MRI being an 
immature modality for common biometry.  Since, EFW is affected by the variability 
of 2D measures, novel approaches, such as 3D volumetric methods in MRI, need 
further investigation if clinical errors are to be reduced in the future.  The assessment 
of calliper placement variations, may be an objective method detecting larger than 
expected errors in fetal measurements. 
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 Appendix: Reporting Checklist 
GRRAS checklist for reporting of studies of reliability and agreement  
  
Version based on Table I in: Kottner J, Audigé L, Brorson S, Donner A, Gajeweski BJ, 
Hróbjartsson A, Robersts C, Shoukri M, Streiner DL. Guidelines for reporting reliability and 
agreement studies (GRRAS) were proposed. J Clin Epidemiol.  2011;64(1):96-106  
  
Section  Item 
#  
Checklist item  Reported 
on page 
#  
Title/Abstract  1  Identify in title or abstract that 
interrater/intrarater reliability or agreement 
was investigated.  
 
Introduction  2  Name and describe the diagnostic or 
measurement device of interest explicitly.  
 
  3  Specify the subject population of interest.   
  4  Specify the rater population of interest (if 
applicable).  
 
  5  Describe what is already known about 
reliability and agreement and provide a 
rationale for the study (if applicable).  
 
Methods  6  Explain how the sample size was chosen. 
State the determined number of raters, 
subjects/objects, and replicate observations.  
 
  7  Describe the sampling method.   
  8  Describe the measurement/rating process 
(e.g. time interval between repeated 
measurements, availability of clinical 
information, blinding).  
 
  9  State whether measurements/ratings were 
conducted independently.  
 
  10  Describe the statistical analysis.   
Results  11  State the actual number of raters and 
subjects/objects which were included and the 
number of replicate observations which were 
conducted.  
 
  12  Describe the sample characteristics of raters 
and subjects (e.g. training, experience).  
 
  13  Report estimates of reliability and agreement 
including measures of statistical uncertainty.  
 
Discussion  14  Discuss the practical relevance of results.   
Auxiliary 
material  
15  Provide detailed results if possible (e.g. 
online).  
 
  
 
